Harvard's David Hunter tells U.S. News and World Report that the scans popping up in the marketplace aren't yet useful for making health decisions for individuals. He has three main concerns about consumers using this technology, namely that they might lull people into a "false sense of security" if their risky genes haven't yet been identified, the overwhelming nature of finding out about multiple disease risks at once, and, lastly, the immature state of knowledge -- the information will need to be updated constantly. "Then there's this other extra area of how to responsibly communicate the information. That needs to be thought through very carefully so we don't do more harm than good," adds Hunter.
Putting the Brakes on Direct-to-Consumer Genome Scans
Jan 10, 2008